Importance of tumour volume and histology in trimodality treatment of patients with Stage IIIA non-small cell lung cancer-results from a retrospective analysis.

Pieter J M JoostenChris DickhoffVincent van den NoortMaarten SmeekensRachel C NumanHouke M KlompJudi N A van DiessenJose S A BelderbosEgbert F SmitKim MonkhorstJan W A OosterhuisMichel M van den HeuvelMax DaheleKoen J Hartemink

Published in: Interactive cardiovascular and thoracic surgery (2021)

Patients with Stage IIIA NSCLC and large tumour volume, as well as patients with adenocarcinoma, who were selected for TT, had favourable outcome compared to patients receiving CRT. This information can be used to assist multidisciplinary team decision-making and for stratifying patients in studies comparing TT and definitive CRT.

Keyphrases

end stage renal disease
decision making
newly diagnosed
small cell lung cancer
ejection fraction
chronic kidney disease
squamous cell carcinoma
palliative care
peritoneal dialysis
patient reported outcomes
healthcare
left ventricular
replacement therapy
case control
tyrosine kinase